Alan A. Musso - 07 Aug 2023 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Chief Financial Officer
Signature
/s/ Greg Tourangeau as attorney-in-fact for Alan Musso
Issuer symbol
FULC
Transactions as of
07 Aug 2023
Net transactions value
$0
Form type
4
Filing time
09 Aug 2023, 16:16:29 UTC
Next filing
02 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +432,800 $0.000000 432,800 07 Aug 2023 Common Stock 432,800 $4.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on August 7, 2023 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of August 7, 2023. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.